DEL(7)(Q32) IS ASSOCIATED WITH A SUBSET OF SMALL LYMPHOCYTIC LYMPHOMA WITH PLASMACYTOID FEATURES

被引:33
作者
OFFIT, K
LOUIE, DC
PARSA, NZ
NOY, A
CHAGANTI, RSK
机构
[1] MEM SLOAN KETTERING CANC CTR,DEPT HUMAN GENET,NEW YORK,NY 10021
[2] MEM SLOAN KETTERING CANC CTR,DEPT MED,NEW YORK,NY 10021
[3] MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021
关键词
D O I
10.1182/blood.V86.6.2365.bloodjournal8662365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletions of the long arm of chromosome 7, previously documented in myelodysplasias and myeloid leukemias, have also been noted in lymphoid malignancies. Of 558 karyotypically abnormal specimens of non-Hodgkin's lymphoma (NHL) serially ascertained over an 8-year period, del(7q) was identified in 24 cases, 10 of which were of the small lymphocytic (sm lym) subtype, Del(7q) was the third most common karyotypic abnormality among the cohort of 61 sm lym cases in this ascertainment, Mapping of the deletions identified a region of common deletion affecting 7q32, which was the sole karyotypic abnormality in 2 cases. Eight of the ten sm lym cases were characterized by plasmacytoid features in histologic sections of lymphoma tumors or circulating cells in the peripheral blood. The del(7)(q32) was accompanied by 14q32-associated translocations in 11 of the 14 cases with histologies other than sm lym, compared with 2 of the sm lym cases. Extranodal involvement was more frequent in the del(7)(q32) sm lym NHLs, although median survival was typical of other low-grade lymphomas, These results suggest that loss or inactivation of a putative tumor-supressor gene at 7q32 may play a role the progression of lymphomas as well as constitute an early event in the pathogenesis of lymphoplasmacytoid tumors. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:2365 / 2370
页数:6
相关论文
共 19 条
[1]  
ARMITAGE P, 1977, STATISTICAL METHODS, P111
[2]   CHROMOSOME-7Q DELETIONS - OBSERVATIONS ON 13 MALIGNANT-TUMORS [J].
ATKIN, NB ;
BAKER, MC .
CANCER GENETICS AND CYTOGENETICS, 1993, 67 (02) :123-125
[3]   LOSS OF HETEROZYGOSITY ON CHROMOSOME-7Q AND AGGRESSIVE PRIMARY BREAST-CANCER [J].
BIECHE, I ;
CHAMPEME, MH ;
MATIFAS, F ;
HACENE, K ;
CALLAHAN, R ;
LIDEREAU, R .
LANCET, 1992, 339 (8786) :139-143
[4]  
HARRIS NL, 1994, BLOOD, V84, P1361
[5]  
KERE J, 1989, BLOOD, V73, P230
[6]   CHROMOSOME-7 LONG-ARM DELETIONS IN MYELOID DISORDERS - TERMINAL DNA-SEQUENCES ARE COMMONLY CONSERVED AND BREAKPOINTS VARY [J].
KERE, J ;
DONISKELLER, H ;
RUUTU, T ;
DELACHAPELLE, A .
CYTOGENETICS AND CELL GENETICS, 1989, 50 (04) :226-229
[7]  
Mertens F., 1991, CATALOG CHROMOSOME A
[8]   CHROMOSOMAL-ABERRATIONS IN NON-HODGKINS-LYMPHOMA - BIOLOGIC AND CLINICAL CORRELATIONS [J].
OFFIT, K ;
CHAGANTI, RSK .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (05) :853-869
[9]   CLINICAL AND MORPHOLOGIC FEATURES OF B-CELL SMALL LYMPHOCYTIC LYMPHOMA WITH DEL(6)(Q21Q23) [J].
OFFIT, K ;
LOUIE, DC ;
PARSA, NZ ;
FILIPPA, D ;
GANGI, M ;
SIEBERT, R ;
CHAGANTI, RSK .
BLOOD, 1994, 83 (09) :2611-2618
[10]   CYTOGENETIC ANALYSIS OF 434 CONSECUTIVELY ASCERTAINED SPECIMENS OF NON-HODGKINS-LYMPHOMA - CORRELATIONS BETWEEN RECURRENT ABERRATIONS, HISTOLOGY, AND EXPOSURE TO CYTOTOXIC TREATMENT [J].
OFFIT, K ;
JHANWAR, SC ;
LADANYI, M ;
FILIPPA, DA ;
CHAGANTI, RSK .
GENES CHROMOSOMES & CANCER, 1991, 3 (03) :189-201